Immune Mediated Necrotizing Myopathy
Also known as: Immune-mediated necrotising myopathy / Immune-mediated necrotizing myopathy / Autoimmune necrotizing myopathy (disorder) / Immune-mediated myositis
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18180 | CT103A | 0 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 0 | Recruiting | 1 |
| DB01073 | Fludarabine | 0 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
| DB00062 | Albumin human | 2 | Withdrawn | 1 |
| DB00028 | Human immunoglobulin G | 2 | Recruiting | 1 |
| DB00028 | Human immunoglobulin G | 2 | Withdrawn | 1 |
| DB09153 | Sodium chloride | 2 | Recruiting | 1 |
| DB15636 | Zilucoplan | 2 | Terminated | 1 |